Publicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (9)

2024

  1. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial

    Revista Espanola de Cardiologia

2023

  1. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

    Medicina Clinica, Vol. 161, Núm. 5, pp. 185-191

2022

  1. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

    Scientific Reports, Vol. 12, Núm. 1

  2. Critical warm ischemia time point for cardiac donation after circulatory death

    American Journal of Transplantation, Vol. 22, Núm. 5, pp. 1321-1328

2021

  1. Colchicine in recently hospitalized patients with COVID-19: A randomized controlled trial (COL-COVID)

    International Journal of General Medicine, Vol. 14, pp. 5517-5526

2020

  1. Impact of pre-hospital renal function on the detection of acute kidney injury in acute decompensated heart failure

    European Journal of Internal Medicine, Vol. 77, pp. 66-72

2019

  1. Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure

    Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 315-319

  2. Population-based Study of First Hospitalizations for Heart Failure and the Interaction Between Readmissions and Survival

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 740-748

2018

  1. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population

    International Journal of Cardiology, Vol. 270, pp. 192-196